Stock Ratings | Guggenheim lowers ACET target to $90, with upside potential remaining at +1,034.93%; Citi lowers SNDK target to $2,100
EyePoint, Inc. EYPT | 0.00 | |
Figure Technology Solutions, Inc. Class A FIGR | 0.00 | |
Zevra Therapeutics, Inc. ZVRA | 0.00 | |
Lyell Immunopharma, Inc. LYEL | 0.00 | |
Adicet Bio Inc ACET | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
Cantor Fitzgerald: Maintaining an "overweight" rating on EyePoint ( EyePoint, Inc.(EYPT.US) ), while raising the price target from $47 to $55.
Bernstein: Maintaining the "Outperform" rating for Figure Technology ( Figure Technology Solutions, Inc. Class A(FIGR.US) ), while raising the price target from $67 to $70.
Citizens: Maintaining its "Outperform Market" rating for Zevra Therapeutics ( Zevra Therapeutics, Inc.(ZVRA.US) ), while raising its price target from $25 to $28.
Stifel: Initial rating for Lyell Immunopharma ( Lyell Immunopharma, Inc.(LYEL.US) ) stock at "Buy", with a target price of $36.
Guggenheim: Maintaining a "buy" rating on Adicet Bio ( Adicet Bio Inc(ACET.US) ), while lowering the price target from $100 to $90.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| EyePoint, Inc.(EYPT.US) | to lift | $55.0 | $12.83 | 328.68% | Cantor Fitzgerald |
| Figure Technology Solutions, Inc. Class A(FIGR.US) | to lift | $70.0 | $28.6 | 144.76% | Bernstein |
| Zevra Therapeutics, Inc.(ZVRA.US) | to lift | $28.0 | $11.88 | 135.69% | Citizens |
| Kratos Defense & Security Solutions, Inc.(KTOS.US) | to lift | $135.0 | $57.41 | 135.15% | Canaccord Genuity |
| Xencor, Inc.(XNCR.US) | to lift | $44.0 | $20.0 | 120.0% | Cantor Fitzgerald |
| Lyell Immunopharma, Inc.(LYEL.US) | Initial classification | $36.0 | $14.21 | 153.34% | Stifel |
| Adicet Bio Inc(ACET.US) | cut | $90.0 | $7.93 | 1034.93% | Guggenheim |
| Nyxoah SA(NYXH.US) | cut | $6.0 | $1.31 | 358.02% | Piper Sandler |
| System1 Inc(SST.US) | cut | $6.5 | $1.66 | 291.57% | Benchmark |
| MannKind Corporation(MNKD.US) | cut | $13.0 | $3.89 | 234.19% | Wells Fargo |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Rosenblatt: Maintaining a "buy" rating on Advanced Micro Devices, Inc.(AMD.US) stock, while raising the price target from $665 to $700.
Bernstein: Maintaining a "Market Match" rating for Amgen Amgen Inc.(AMGN.US) ) stock, while raising the price target from $335 to $345.
Barclays: Maintaining a "market-matched weight" rating for Caterpillar Caterpillar Inc.(CAT.US) ) stock, while raising its price target from $800 to $900.
Truist Securities: Maintaining a "Hold" rating on Duolingo Duolingo, Inc.(DUOL.US) ) stock, while raising the price target from $100 to $120.
UBS: Maintaining a "neutral" rating on Shopify Shopify, Inc. Class A(SHOP.US) ) stock, while raising its price target from $130 to $145.
RBC Capital: Maintaining a "sector-match" rating for SanDisk ( Sandisk Corporation(SNDK.US) ), while raising its price target from $1,000 to $1,300.
First Coverage
Stifel: Initial rating for Lyell Immunopharma ( Lyell Immunopharma, Inc.(LYEL.US) ) stock at "Buy", with a target price of $36.
HC Wainwright & Co.: Initial rating for Atrium Therapeutics ( Atrium Therapeutics(RNA.US) ) at "Buy", with a target price of $25.
reduction
Needham: Maintaining a "buy" rating on AppLovin ( AppLovin(APP.US) ), while lowering the price target from $700 to $500.
Morgan Stanley: Maintaining an "underweight" rating on Circle Internet Group ( Circle(CRCL.US) ), while lowering the price target from $38 to $37.
Guggenheim: Maintaining a "neutral" rating on McDonald's McDonald's Corporation(MCD.US) ) stock, while lowering its price target from $320 to $290.
Barclays: Maintaining an "overweight" rating on Uber Uber Technologies,Inc.(UBER.US) ) stock, while lowering its price target from $107 to $106.
DA Davidson: Maintaining a "buy" rating on Uber Uber Technologies,Inc.(UBER.US) ) stock, while lowering the price target from $107 to $100.
Citigroup: Maintaining a "buy" rating on SanDisk ( Sandisk Corporation(SNDK.US) ) stock, while lowering the price target from $2,500 to $2,100.
Wells Fargo: Maintaining a "market-matched weight" rating for SanDisk ( Sandisk Corporation(SNDK.US) ), while lowering its price target from $1,620 to $1,400.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.